Michael A. Eldon
8Patents
3h-index
25Co-inventors
53Inventor score
Filing activity: Jun 21, 2005 → Oct 3, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8900555B2 | Insulin derivative formulations for pulmonary delivery | Human Necessities | 11 | Active |
| US7326691B2 | Compositions comprising amphotericin B, methods, and systems | Human Necessities | 7 | Expired |
| US8906353B2 | Compositions and methods for achieving sustained therapeutic drug concentrations in a subject | Human Necessities | 7 | Active |
| US9801873B2 | Methods for treating humans having brain cancer | Human Necessities | 3 | Active |
| US10525051B2 | Compositions and methods for achieving sustained therapeutic drug concentrations in a subject | Human Necessities | 3 | Active |
| US10132810B2 | Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor | Physics | 3 | Active |
| US8404217B2 | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use | Human Necessities | 1 | Active |
| US11033631B2 | Methods of treating CYP2D6 alternative metabolizers | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.